Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion description "[In this study, we have used a combination of transcriptomics and proteomics technologies to investigate the response of human hepatoma PLC/PRF/5 cells to prohibitin silencing to define in detail the biological function of hepatic Phb1 and to elucidate potential prohibitin-dependent mechanisms participating in the maintenance of the transformed phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion evidence source_evidence_literature NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion SIO_000772 20186755 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion wasDerivedFrom befree-20140225 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_assertion wasGeneratedBy ECO_0000203 NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP658743.RACrIbWDVlvE_2m5tVdbnlRuevXAVU_e6zLnA1o8y0_EY130_provenance.